Trials / Completed
CompletedNCT04503629
A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
A Phase 2,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase 2,double-blinded, double dummy, parallel, positive drug, randomised controlled multicenter trial to evaluate efficacy and safety of 4 weeks treatment of Anaprazole 20mg QD, 40mg QD compared with rabeprazole 10mg QD in patients with duodenal ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anaprazole Sodium | Anaprazole Sodium 20mg |
| DRUG | Anaprazole Sodium | Anaprazole Sodium 40mg |
| DRUG | Rabeprazole sodium | Rabeprazole sodium 10mg |
Timeline
- Start date
- 2018-10-09
- Primary completion
- 2019-05-17
- Completion
- 2019-05-17
- First posted
- 2020-08-07
- Last updated
- 2020-08-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04503629. Inclusion in this directory is not an endorsement.